Showing results (41-50 of 681) with videos related to
Sort By:
Pageof 69
Annals of Hematology|February 14, 2023
How I manage anemia related to myelofibrosis and its treatment regimensSrdan VerstovsekClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosisSrdan VerstovsekLeukemia Research|November 18, 2008
Preclinical and clinical experience with dasatinib in Philadelphia chromosome-negative leukemias and myeloid disordersSrdan VerstovsekEuropean Journal of Haematology|November 28, 2012
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progressionSrdan VerstovsekLeukemia Research|June 12, 2017
Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosisLucia Masarova, Prithviraj Bose, Naval Daver, et al.Cancer|July 23, 2020
Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib eraLucia Masarova, Prithviraj Bose, Naveen Pemmaraju, et al.Blood Advances|July 28, 2019
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosisJason Gotlib, John H Baird, Tracy I George, et al.Cancer|January 25, 2022
Improved survival of patients with myelofibrosis in the last decade: Single-center experienceLucia Masarova, Prithviraj Bose, Naveen Pemmaraju, et al.Expert Review of Anticancer Therapy|May 19, 2009
Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasmsEhab Atallah, Srdan VerstovsekExpert Opinion on Emerging Drugs|November 29, 2012
Emerging drugs for myelofibrosisEhab Atallah, Srdan VerstovsekPageof 69